Dr. Milan Chag
MD, DM (Cardiology), DNB (Cardiology)
Managing Director  - The Heart Care Clinic

Mobile : 98240 22107

   
NAME

MILAN CHINUBHAI. CHAG
MD (Medicine), DM (Cardiology)
Diplomate of National Board (Cardiology)
Neonatal and Pediatric Intervention Specialist
PERMANENT ADDRESS

15, Heritage Residency
Thaltej Shilaj Road
Thaltej
Ahmedabad.
OFFICE ADDRESS

The Heart Care Clinic          
2nd Floor, Balleshwar Avenue
Opp. Rajpath Club, S G Highway
Ahmedabad - 380 015 Gujarat, India.
Phones : + 91 79 26873101, + 91 79 26873325, + 91 79 26873224, + 91 79 26871564
Fax : + 91 79 26872195
Ahmedabad Office Mobile : +91 98250 66664, +91 98250 66668 Rajkot Office Mobile : +91 94265 20474

EMAIL mcchag@gmail.com, milan.chag@heartcareclinic.org
DATE OF BIRTH June 1, 1960.
NATIONALITY Indian
MARITAL STATUS Married
SPOUSE Preeta
CHILDREN Aenasha and Tanisha
PRESENT AFFILIATION

Interventional Cardiologist at Sterling Hospital
Apollo Hospital
Krishna Heart Institute

Chief Neonatal and Pediatric Intervention specialist.
FORMER AFFILIATION

S. A. L. Hospital & Medical Institute
Apollo Hospital
Krishna Heart Institute
Sheth V.S. General Hospital, Ahmedabad

Chief Neonatal and Pediatric Intervention specialist.
EDUCATIONAL QUALIFICATIONS

(All Examinations were passed at First Attempt with First Class).

SR.NO EXAMINATION INSTITUTE YEAR

1.

SSCE

NMHS, Jamnagar

 March 1976

2.

MBBS

M.P.Shah Medical College Jamnagar

 June 1978 to
 November 1982

3.

MD(Medicine)

M.P.Shah Medical College Jamnagar

 January 1984 to
 November 1986

4.

DNB(Cardiology)

Jaslok Hospital & Research Centre,
Bombay

 August 1987 to
 July 1989

5.

DM(Cardiology)

Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow

 January 1991 to
 December 1993
REGISTRATION NUMBER G - 13842
HONOURS, SCHOLARSHIPS AND ACHIEVEMENTS
  • Best Outgoing Student at school for securing first rank at each of examinations all throughout the undergraduate study.
  • National Merit Scholarship Awarded by Secondary School Certificate Board of Gujarat for excellence at SSC Examination.
  • Post-Graduate Merit scholarship Awarded by Saurashtra University for excellence at MBBS Examination.
  • First Doctor from Gujarat to possess two highest Degrees in Cardiology (DM and DNB).
  • Pioneer in establishing Pediatric Cardiology Services and Treatment in Gujarat.
  • First Cardiologist from Gujarat (Along with his colleagues) to Present a paper at Chicago in American College Cardiology Conference in March 2003.
CARDIOLOGY EXPERIENCE
  • Registrar in Cardiology at Jaslok Hospital and Research Center, Bombay between 1.8.1987 & 31.7.1988 (1 Year).
  • Senior Registrar in Cardiology at Jaslok Hospital and Research Centre, Bombay between 1.8.1988 to 31.7.1989 (1 Year).
  • Fellow in Cardiology at Christian Medical College Hospital, Vellore between 11.9.1989 and 10.11.1989 (2 Months).
  • Senior Resident in Cardiology at Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow between 16.3.1990 to 31.12.1993 (3 Years, 8 ˝ Months).
  • Consultant in Cardiology at Institute of Cardiology and Research Centre, Civil Hospital, Ahmedabad between 1.2.1994 to 30.9.1995 (1Year, 8Months).
  • Total Experience in Cardiology since 1986.
  • Practicing Interventional Cardiologist since 1995.
  • Total Teaching Experience (Medicine Plus Cardiology) over 18 Years.
  • Obtained extensive training in Clinical, Noninvasive and Interventional Cardiology which includes
    • Cardiac Catheterization and Coronary Angiography: Over 13,000.
    • Coronary Angioplasty (including intracoronary stent, atherectomy, rotablation) : Over 3000.
    • Percutaneous Transvenous Mitral Commissurotomy (Ballon Mitral Valvuloplasty): Over 1500.
    • Balloon Pulmonary, Aortic and Tricuspid Valvuloplasoty, Balloon of congenital or acquired Coarctation of aorta, renal and peripheral artery angioplasty and balloon atrial septostomy (many of these procedures were done in sick newborns and infants) : Over 500.
    • Permanent Pacemaker Implantation: Over 200.
    • Electrophysiological Study and catheter ablation for tachyarrhythmias.
    • Pioneer in establishing Pediatric Cardiology and Pediatric Cardiac Interventions in Gujarat State

Scientific Committee-Chairman
    1. 3-C Con 2010 (Jan 9 - 11, 2009) – Tagore Hall, Ahmedabad: Organized by The Heart Care Clinic.
    1. 3-C Con 2009 (Jan 9 - 11, 2009) – Tagore Hall, Ahmedabad: Organized by The Heart Care Clinic.
    2. 3-C Con 2008 (Jan 11- 13, 2008) – Tagore Hall, Ahmedabad: Organized by The Heart Care Clinic.
    3. 3-C Con 2007 (Jan 26 – 28, 2007) – “Recent Updates in Cardiovascular Medicine”, Tagore Hall, Ahmedabad: Organized by The Heart Care Clinic.
    4. 3-C Con 2006- Novelties and Advances in Cardiovascular Medicine, Nirma University, Ahmedabad: Organized by The Heart Care Clinic.
    5. “Joint International Conference” (JIC) -2005, 31st Dec 2004 to 2nd Jan 2005.( 800 + delegates conference with over 50 International Faculty.

    Jointly Organized by:
    1) Care Cardiovascular Consultants
    2) International Academy of Cardiovascular Sciences (India Section)
    3) International Society for Heart Research (India Section)
    In Association with    :
    4) American Association of Physicians of Indian Origin (AAPI)
    5) American Association of Cardiologists of Indian Origin (AACIO)
   
RESEARCH WORK, PUBLICATIONS AND PRESENTATIONS

  • Dissertation: “Clinical Profile of Right Ventricular Infraction” submitted to Saurashtra University for MD Examination November 1986.

  • Dissertation: “99m Technetium Isonitriles - New Myocardial Perfusion Agents: A Comparison with Coronary Angiography in Patients with Coronary Artery Disease” submitted to The National Board of Examination, New Delhi for DNB (Cardiology) Examination, February 1990.

  • Yajnik V.H., Chag M.C., Glimpses of Progress in Management of Essential Hypertension, in “Current Concepts in Cardiology,” in Kothari U.R., Oza Y.K., (eds) Jamnagar, Association of physicians of Gujarat, 1987, P.46.

  • Vatsraj D.J., Chag M.C., Jadhav U.M. : Refractory Heart Failure, in “Current Concepts in Cardiology” in Kothari U.R., Oza Y.K.,(eds.) jamnagar, Association of  Physicians of Gujarat, 1987, P.124.

  • Yajnik V.H., Vatsraj D.J., Jobanputra R.H., Chag M.C., Vacchani M.P.: A Comparative Evaluation of Two Antidiarrhoeal Agents in Acute Diarrhoea in Adults. Guj. Medical J 1986, 10:108.

  • Chag M.C., Kulkarni P.S. : Clinical Profile of Right Ventricular Infarction : Presented as Paper in 8th Annual Conference of Association of physicians of Gujarat, Jamnagar, 1987.

  • Mehta A.B., Munsi S.C., Chag M.C., Henda S : Percutaneous Transluminal Coronary Angioplasty in Multivessel Coronary Artery Disease. Indian Heart J 1989; 41:1.

  • Chag M.C., Sinha N.S., Goel P.K.: Dipyridamole Echocardiography for Severity and location of Coronary Artery Disease. Indian heart J 1992; 44:300.

  • Chag M.C., Sinha N.S., Radhakrishnan S., Bidwai P.S.: Non-Specific Aortoarteritis: Clinical, Immunological and Angiographic profile and Follow-up. Indian Heart J 1992; 44:295.

  • Shah S, Chag M.C., Mantri R.R., Lal M., Bajaj R., Ghosh P.K. : Tricuspid Annuloplasty: obajective Analysis of its Efficacy. Scientific Abstract: Annual Conference of Indian Association of cardiovascular and Thoracic Surgeons: Feb. 1992, Calcutta, India, P.50.

  • Rastogi N., Chag M.C., Ayyagari S: Myocardial Ischemia after 5-Fluorouracil chemotherapy. International J Cardiol 1993; 42:285-287.

  • Shrivastava S, Chag M.C.: Balloon Mitral Valvuloplasty for Rheumatic Mitral Stenosis, in “Recent Advances in Cardiology, In Trehan None, Anil Kumar (eds.) New Dehli, Escort Heart Institute, 1993.

  • Agarwal A, Misra R, Chag M.C., Sinha N.: Elevated Anticardiolipin Antibiodies in Takayasu’s Arteritis. Presented a Paper in Annual Conference of Rheumatology, New Dehli, 1993.

  • Agarwal A, Sinha S, Chag M.C., Naik S: HLA Antigens in Aortoarteritis: Presented as Paper in National Symposium on HLA, New Dehli, 1993.

  • Agarwal A, Sinha S, Chag M.C., Naik S: Takayasu’s Arteritis: Roal of mycobacterium Tuberculosis in its Pathogenesis: Presented as paper in Annual Conference Rheumatology, New Dehli, 1993.

  • Misra R, Agarwal A, Chag M.C., Sinha N., Shrivastava S. : Elevated Anticardiolipin Antibodies in Takayasu’s Arteritis:Lancet 1994; 343  : 1644-1645.

  • Chag M.C., Dani S.I., Patel T.M., Thakore S.B., Rawal J.R., Patel TK: Situs          abnormality and Cardiac Malpositions. Indian Heart Pulmonary  Stenosis, Study of 42 cases: Indian Heart J 1994; 46;220.

  • Dani S.I., Patel T.M., Chag M.C., Rawal J.R., Thakore S.B., Shah U.G., Patel T.K. : Balloon Pulmonary Valvuloplasty in Adult Pulmonary Stenosis, Study of 42 cases : Indian Heart J. 1994; 46:220.

  • Chandra Y.V., Chag M.C., Kapoor L., Mittal P.K. Mahant T.S., Srivastava A.K., Ghose P.K., Srivastava S.: Fate of Tricuspid Regurgitation in Mitral valve Disease after surgery with/without Tricuspid valve Annuloolasty. Indian Heart J 1994; 46:259.

  • Dani S.I., Patel T.M., Chag M.C., Patel T.K.: Modified Inoue Technique for BMV in Difficult situations: Indian Heart J 1994; 46:259.

  • Patel T.M., Dani S.I., Chag M.C., Patel T.K., : Coronary Angioplasty in Chronic total occlusions. Indian Heart Journal 1994; 46:250.

  • Patel T.M., Dani S.I., Chag M.C., Thakore S.B., Rawal J.R., Shah S.C., Patel T.K., : Balloon Peripheral Angioplasty in Iliofemoral Disease. Indian Heart J 1994; 46:252.

  • Mishra R., Prasad N., Agarwal A., Chag M.C., Sinha N., Shrivastava S., : Raised Anticardiolipin Antibody in Takayasu’s Arteritis: Indian Heart J 1994; 46:253.

  • Dani S.I., Patel T.M., Chag M.C., Thakore S.B., Patel T.K., Difficult Mitral Valvuloplasty: An “over the wire” modification of  Inoue Technique: J Invasive Cardiology 1995; 7:148-151.

  • Patel T.M., Dani S.I., Chag M.C., Shah U.G., Shah S.C., Patel T.K.: Troubleshooting of inoue balloon Tear during Percutaneous Balloon Mitral Valvuloplasty: J Cathet cardiovasc Diagn (in Press).

  • Lal M., Mantri R.R., Chag M.C., Ganjoo A.K., Srivastav A.K., Mahant T.S., : Echocardiographic assessment and outcome of closed and open heart surgery in patients with rheumatic tricuspid valve disease: Tropical Cardiology 1994; 20 (78): 54-60.

  • Aggarwal A, Chag M.C., Shinha N., Naik S.: Takayasu’s Arteritis: Roal of Mycobacterium tuberculosis and its 65 KD heart shock protein in pathogenesis: Annals of Rheumatic Diseases (In Press).

  • Chag M.C., Patel T.M., Dani S.I., Thakore S.B., Rawal J.R., Jain S.K., Patel T.K.,: A Left Femoral Vain Approach For Percutaneous Tranvenous Mitral Commissurotomy: J Invasive Cardiology (In Press).

  • Mehta K.N., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik AM, Goyal R.K. Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study: Indian J Pharmacol. (Abstract)

  • Parikh K.H., Chag M.C, Shah U.G, Baxi H.A., Chandarana A.H., Naik A.M, Goyal R.K., Shah K.J. Acute results and Intermediate term follow up of PCI with Cardioprotection by Balloon Occlusion Distal Protection Device. Indian Heart J. J-233, 2002; 54: 561-568.

  • Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M.,Shah K.J., Goyal R.K. Reversal of Slow-Flow or No-Reflow in PTCA using Boluses of IC Adenosine and Sodium Nitroprusside. Suppl to JACC, March 19, 2003; 41 (6), Suppl A: 1101- 201

  • Shah K.J., Chag M.C., Parikh K.H., Goyal R.K. Homocysteine and Coronary Artery Disease (Review). Indian Pharmaceutical Sciences (submitted).

  • Shah K.J., Chag M.C. Homocysteine- A risk marker for coronary artery disease. CMJ North Zone 2003: 9, No: 2: 23- 26.

  • Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah HD, Goyal RK. Beneficial Effects Of Distal Protection Device In Reducing The Use Of Intracoronary Vasodilators And Glycoprotein IIb/IIIa Receptor Antagonists During Percutaneous Coronary Interventions. Poster Presentation at Annual Conference of Society of Cardiovascular Angiography and Interventions (SCAI), San Diego, May 2004 Abstract published in Catheter and Cardiovasc Interven 2004; 62: pg 90.

  • Parikh KH, Shah HD, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Revascularization In Acute Myocardial Infarction Using Percusurge In Distal Protection (RAPID).  Poster Presentation at Annual Conference of Society of Cardiovascular Angiography and Interventions (SCAI), San Diego, May 2004. Abstract published in Catheter and Cardiovasc Interven 2004; 62: pg 116.

  • Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah HD, Goyal RK. Improvement In Mace By Sequential Administration Of Boluses Of Intracoronary Adenosine And Sodium Nitroprusside During Percutaneous Coroanry Interventions. Poster Presentation at Annual Conference of Society of Cardiovascular Angiography and Interventions (SCAI), San Diego, May 2004. Abstract published in Catheter and Cardiovasc Interven 2004; 62: pg 130-131.

  • Parikh KH, Shah HD, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK. Improvement In Mace By Sequential Administration Of Boluses Of Intracoronary Adenosine And Sodium Nitroprusside During Percutaneous Coronary Interventions. (Poster Presentation at Annual Congress) European Society of Cardiology, 2004, Munich, Germany.

  • Parikh KH, Shah HD, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Shah JN, Goyal RK. Revascularization In Acute Myocardial Infarction Using Percusurge In Distal Protection (RAPID). World Heart J (Submitted)

  • Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah KJ, Goyal RK. Beneficial effects of addition of fenofibrate to statins in acute coronary syndrome patients undergoing Percutaneous Coronary Interventions. World Heart J (Submitted)

  • Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah KJ, Goyal RK. Effect of Statins in combination with fenofibrate on Plasma fibrinogen: A cardiovascular risk factor. Pharmacol Res (Submitted)
CLINICAL RESEARCH ACCOMPLISHED
  1. Effect of Folate treatment on Homocysteinemia in cardiac patients: A Prospective Study.
  1. Pharmacoepidemiology and Risk factors of Hypertension in Gujarat.
  1. Reversal of slow or no- reflow During Percutaneous Transluminal Coronary Angioplasty Using Boluses of Intracoronary Adenosine and Sodium Nitroprusside in combination.
  1. Acute Results of Intermediate – term follow up of Percutaneous Transluminal Coronary Angioplasty with Cardioprotection by Balloon Occlusion Distal Protection Device.
  1. Effect of Tirofiban HCl in Patients with Acute Coronary Syndrome and its comparison with other GPIIb/IIIa antagonists such as Abciximab and Eptifibatide - A Registry by Zydus Cadila.
  1. Revascularization Utilizing Balloon Protection in Acute Coronary ischemic Syndrome- An International Registry by Medtronic India Ltd.
  1. An International Registry of CYPHER TM-Sirolimus eluting stent by Cordis, Johnson and Johnson.
  1. High prevalence of Renal Artery Stenosis in Hypertensive patients with Triple vessel Coronary Artery Disease.
  1. Effects of Combination of Statins and Fenofibrates with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention.
  1. Effect of Pioglitazone and its combination with Statins in Coronary Artery Disease patients with Hsyperinsulinemia.
  1. Comparison of Drug eluting stent with S7 stent.
  1. Assessment of Risk factors for Coronary Artery Disease.
  1. Effect of Niacin treatment on hyperlipoproteinemia in Coronary Artery Disease patients.
  1. Beneficial effects of Distal Protection Device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions.
  1. Comparison of Total Procedural time involved in Primary PCI with or without the use of Distal Balloon Protection system in Thrombotic Coronary lesions. (RAPID trial- Revascularization in Acute myocardial infarction using Percusurge In Distal protection)

INTERNATIONAL CLINICAL TRIALS

1

Co-Investigator For PAPIRUS Trial: Pilot Study, First in Human: Apollo Hospital

Implantable Ultrasonic device for PA pressure
measurement in Heart failure

10 patients successfully done (all at Apollo Hospital, India)

2

Co-Investigator for Pilot Study, First in human:
SAL Hospital

Coronary Sinus stent like device for
retroperfusion in Coronary Artery Disease

10 patients successfully completed (out of 15 patients worldwide)- Presented at TCT, 2005

3

Co-Investigator for RUBY registry (For India)

To evaluate Percusurge / Guardwire
Distal Protection Device (Presented by Dr. Aman, Switzerland)

 Presented TCT October 2003

 

4

Co-Investigator at Sterling Hospital for Extract-TIMI 25 Multicentre multi national Trial

LMWH and Thrombolysis
Reperfusion for Acute Myocardial
Infarction Treatment
Thrombolysis in Myocardial Infarction –
Study 25

  

5

Co-Investigator at SAL Hospital for  OASIS-5 Trial

LMWH   in Acute Coronary Syndrome

Presented in ESC, Stockholm, Sweden

6

Co-Investigator at SAL Hospital for  OASIS-6 Trial

LMWH in Acute Myocardial Infarction

Presented in ACC

7

Co-Investigator for TRUST Trial at SAL Hospital , Ahmedabad
India.

Prostacyclin Analogue in Pulmonary
Hypertension

 

8

Principal Investigator for Paediatric Hypertension Trial

Angiotensin Receptor Blocker in Paediatric Hypertension

 

9.

Principal Investigator for Paediatric Hypertension Trial

ACE Inhibitor in Paediatric Hypertension

 

10

Co-Investigator For EXPORT Study

Aspiration catheter in Acute Myocardial Infarction

  

11

Principal Investigator For Hypercholesterolemia Study

Newer Generation of statin in Hyperlipidemia

  

12

Co-Investigator for BI-RELY Study

Anticoagulant therapy in non-valvular Atrial Fibrillation

 

13

Co-Investigator for POLYCAP study

 

  

14

Principal Investigator for Stable Angina Pectoris Study

Stable Angina Pectoris Study

Will be started in February 2007

15

P.I for ACCUNOVA at SAL Hospital, Ahmedabad India.

To evaluate the safety and efficacy of
GPIIb/IIIa inhibitor in Indian patients
scheduled for Percutaneuos Coronary
Intervention.

Ongoing

16

Co-Investigator for Bivaflo Registry at SAL Hospital, Ahmedabad, India

To evaluate the efficacy and safety of
BIVAFLO® as an adjunctive therapy during
PCI in moderate–high risk ACS patients with
provisional GP IIb/IIIa inhibitors use.

Ongoing
   
ADDENDUM
In-house Scientific Projects

SR NO

TITLE

REFERENCE

1

Short term and Long term effect of Metoprolol CR/XL on PAP in patients with CHF using first in human implantable device responding to ultransonic signal

CHF

2

Diurnal variation in PA pressure measured using First in Human implantable device responding to ultrasonic signals

CHF

3

Acute effects on Pulmonary artery pressure, on rest and after exercise in patients in patients with heart failure (EF<35%) using first in human implantable device for PAP responsing to ultrasonic signals

CHF

4

Effect of Metoprolol CR/XL on diurnal variation in Pulmonary artery pressure in Heart failure patients using first in man implantable device responding to ultrasonic signals

CHF

5

Effect of Metoprolol CR/XL on Pulmonary artery pressure before and after exercise in Heart failure patients using first in man implantable device responding to ultrasonic signals

 

6

First in human CT angiography images of “Pulmonary artery Stenting with a transducer device” in patients with heart failure

CHF

7

Correlation Between Multislice CT Angiography, 2D- Echocardiography And Invasive Angiography For Determination Of Pulmonary Artery Size

CHF

8

First in human pilot study of safety and efficacy of Neovasc Reducer Implant in the treatment of ischemic heart disease by controlled narrowing of the coronary sinus, in patients with No-Options

CAD

9

Evaluation of Coronary arterial system and collaterals subsequent to first in human Neovasc ReducerTM Implantation in Coronary Sinus in “No Options” patients using 40 Slice Multi-detector Computed Tomography

CAD

10

Non invasive Visualization of first in human Neovasc ReducerTM Implant in Coronary Sinus using 40 Slice Multi-detector Computed Tomography

CAD

11

Direct Comparison Of Conventional Coronary Sinus Angiography And CT Angiography For Visualization And Sizing Of Coronary Sinus

 

12

Effect of Coronary Sinus Retroperfusion Stent (Neovasc Reducer®) on angiogenic , inflammatory and genetic markers

CAD
TOP  
 
                                                                                                                  ©Copyright 2006 The Heart Care Clinic